ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.729,40
-0,73%
S&P 500
5.267,84
-0,74%
US Dollar vs BRL
5,1446
-0,16%
Bitcoin
67.711,82
-2,01%
Brent Oil
81,31
-0,27%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aethlon Medical Inc (AEMD)

  7. Aethlon Medical Inc (AEMD) Notícias

AEMD

Aethlon Medical (AEMD)

Aethlon Medical Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEMD
DataHoraFonteTítuloCódigoCompanhia
17/05/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AEMDAethlon Medical Inc
17/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AEMDAethlon Medical Inc
16/05/202417:05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:AEMDAethlon Medical Inc
15/05/202410:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AEMDAethlon Medical Inc
15/05/202410:15PR Newswire (US)Aethlon Medical Announces Pricing of $4.7 Million Public OfferingNASDAQ:AEMDAethlon Medical Inc
13/05/202418:30Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AEMDAethlon Medical Inc
10/05/202409:01PR Newswire (US)Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaNASDAQ:AEMDAethlon Medical Inc
21/02/202410:01PR Newswire (US)Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesNASDAQ:AEMDAethlon Medical Inc
14/02/202419:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AEMDAethlon Medical Inc
14/02/202418:15PR Newswire (US)Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
07/02/202410:00PR Newswire (US)Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024NASDAQ:AEMDAethlon Medical Inc
02/01/202420:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
22/12/202318:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AEMDAethlon Medical Inc
14/11/202318:15PR Newswire (US)Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
13/11/202310:01PR Newswire (US)Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating OfficerNASDAQ:AEMDAethlon Medical Inc
06/11/202310:01PR Newswire (US)Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023NASDAQ:AEMDAethlon Medical Inc
10/10/202309:01PR Newswire (US)Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in OncologyNASDAQ:AEMDAethlon Medical Inc
04/10/202309:01PR Newswire (US)Aethlon Announces Reverse Stock SplitNASDAQ:AEMDAethlon Medical Inc
30/08/202309:01PR Newswire (US)Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AEMDAethlon Medical Inc
10/08/202317:15PR Newswire (US)Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
03/08/202309:01PR Newswire (US)Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023NASDAQ:AEMDAethlon Medical Inc
27/07/202317:19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AEMDAethlon Medical Inc
27/07/202317:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AEMDAethlon Medical Inc
24/07/202309:01PR Newswire (US)Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for TransplantNASDAQ:AEMDAethlon Medical Inc
17/07/202317:43Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AEMDAethlon Medical Inc
06/07/202318:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AEMDAethlon Medical Inc
06/07/202315:17PR Newswire (US)Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of DirectorsNASDAQ:AEMDAethlon Medical Inc
28/06/202318:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AEMDAethlon Medical Inc
28/06/202318:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AEMDAethlon Medical Inc
28/06/202317:15PR Newswire (US)Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate UpdateNASDAQ:AEMDAethlon Medical Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AEMD

Seu Histórico Recente

BIT
EMKT
Amundi MSCI Emerging Mar...
BIT
UR9ZPH
UniCredit Bank
BIT
F16094
Vontobel Financial Produ...
USOTC
VRSRF
Versarien (PK)
NYSE
EIF
POLO
REKTUSDT
REKT
DBI
I1HT
DAX Monthly Hedged JPY TTM
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados